Financhill
Sell
21

KPTI Quote, Financials, Valuation and Earnings

Last price:
$4.41
Seasonality move :
-6.23%
Day range:
$3.70 - $4.58
52-week range:
$3.51 - $16.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.28x
P/B ratio:
--
Volume:
1.7M
Avg. volume:
122.8K
1-year change:
-68.48%
Market cap:
$39.3M
Revenue:
$145.2M
EPS (TTM):
-$13.27

Karyopharm Therapeutics SEC Filings

Company Filed Form Type Description
KPTI
Karyopharm Therapeutics
05/08/2024 10-Q 10-Q filing on 05/08/2024 View Form
KPTI
Karyopharm Therapeutics
11/02/2023 10-Q 10-Q filing on 11/02/2023 View Form
KPTI
Karyopharm Therapeutics
08/02/2023 10-Q 10-Q filing on 08/02/2023 View Form
KPTI
Karyopharm Therapeutics
05/04/2023 10-Q 10-Q filing on 05/04/2023 View Form
KPTI
Karyopharm Therapeutics
11/03/2022 10-Q 10-Q filing on 11/03/2022 View Form
KPTI
Karyopharm Therapeutics
08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
KPTI
Karyopharm Therapeutics
05/05/2022 10-Q 10-Q filing on 05/05/2022 View Form
KPTI
Karyopharm Therapeutics
11/03/2021 10-Q 10-Q filing on 11/03/2021 View Form
KPTI
Karyopharm Therapeutics
08/05/2021 10-Q 10-Q filing on 08/05/2021 View Form
KPTI
Karyopharm Therapeutics
05/04/2021 10-Q 10-Q filing on 05/04/2021 View Form
KPTI
Karyopharm Therapeutics
11/02/2020 10-Q 10-Q filing on 11/02/2020 View Form
KPTI
Karyopharm Therapeutics
08/04/2020 10-Q 10-Q filing on 08/04/2020 View Form
KPTI
Karyopharm Therapeutics
05/05/2020 10-Q 10-Q filing on 05/05/2020 View Form
KPTI
Karyopharm Therapeutics
02/26/2020 10-K 10-K filing on 02/26/2020 View Form
KPTI
Karyopharm Therapeutics
11/04/2019 10-Q 10-Q filing on 11/04/2019 View Form
KPTI
Karyopharm Therapeutics
08/07/2019 10-Q 10-Q filing on 08/07/2019 View Form
KPTI
Karyopharm Therapeutics
05/09/2019 10-Q 10-Q filing on 05/09/2019 View Form
KPTI
Karyopharm Therapeutics
02/28/2019 10-K 10-K filing on 02/28/2019 View Form
KPTI
Karyopharm Therapeutics
11/08/2018 10-Q 10-Q filing on 11/08/2018 View Form
KPTI
Karyopharm Therapeutics
08/07/2018 10-Q 10-Q filing on 08/07/2018 View Form
KPTI
Karyopharm Therapeutics
05/10/2018 10-Q 10-Q filing on 05/10/2018 View Form
KPTI
Karyopharm Therapeutics
03/15/2018 10-K 10-K filing on 03/15/2018 View Form
KPTI
Karyopharm Therapeutics
11/02/2017 10-Q 10-Q filing on 11/02/2017 View Form
KPTI
Karyopharm Therapeutics
08/08/2017 10-Q 10-Q filing on 08/08/2017 View Form
KPTI
Karyopharm Therapeutics
05/04/2017 10-Q 10-Q filing on 05/04/2017 View Form
KPTI
Karyopharm Therapeutics
03/16/2017 10-K 10-K filing on 03/16/2017 View Form
KPTI
Karyopharm Therapeutics
11/07/2016 10-Q 10-Q filing on 11/07/2016 View Form
KPTI
Karyopharm Therapeutics
08/04/2016 10-Q 10-Q filing on 08/04/2016 View Form
KPTI
Karyopharm Therapeutics
05/09/2016 10-Q 10-Q filing on 05/09/2016 View Form
KPTI
Karyopharm Therapeutics
03/15/2016 10-K 10-K filing on 03/15/2016 View Form
KPTI
Karyopharm Therapeutics
11/09/2015 10-Q 10-Q filing on 11/09/2015 View Form
KPTI
Karyopharm Therapeutics
08/10/2015 10-Q 10-Q filing on 08/10/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Microsoft Be a $5 Trillion Stock?
Will Microsoft Be a $5 Trillion Stock?

Microsoft’s market capitalization sits near $3.73 trillion today. To clear the…

Where Will C3.ai Stock Be in 1 Year?
Where Will C3.ai Stock Be in 1 Year?

C3 .ai (NYSE: AI) has been the poster child for “hype versus execution.”…

What Is the Ceiling for IONQ Stock?
What Is the Ceiling for IONQ Stock?

IonQ (NYSE:IONQ) is a quantum computing startup that, like many…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 12

MiNK Therapeutics [INKT] is up 727.94% over the past day.

Buy
51
NEGG alert for Jul 12

Newegg Commerce [NEGG] is up 74.03% over the past day.

Buy
68
ATRO alert for Jul 12

Astronics [ATRO] is up 16.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock